![2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide structure](/static/products/799/799770-60-8.png)
2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide
TL;DR: 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide (CAS 799770-60-8) is a chemical compound with molecular formula C25H21BrN4O2 and molecular weight 488.08 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
2-bromo-N-[(E)-3-[2-(1H-indol-3-yl)ethylamino]-3-oxo-1-pyridin-3-ylprop-1-en-2-yl]benzamide
Also Known As: 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide, (E)-N-(3-((2-(1H-indol-3-yl)ethyl)amino)-3-oxo-1-(pyridin-3-yl)prop-1-en-2-yl)-2-bromobenzamide, 2-bromo-N-[(1E)-3-{[2-(1H-indol-3-yl)ethyl]amino}-3-oxo-1-(pyridin-3-yl)prop-1-en-2-yl]benzamide, 2-bromo-N-[(E)-3-[2-(1H-indol-3-yl)ethylamino]-3-oxo-1-pyridin-3-ylprop-1-en-2-yl]benzamide
| Molecular Formula | C25H21BrN4O2 |
|---|---|
| Molecular Weight | 488.08 g/mol |
| LogP | 4.4552 |
| Topological Polar Surface Area | 86.88 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 7 |
| Exact Mass | 488.08478 |
| Heavy Atoms | 32 |
| Complexity | 1281.3612 |
Chemical Identifiers
| CAS Number | 799770-60-8 |
|---|---|
| SMILES | C1=CC=C2C(=C1)C(=CN2)CCNC(=O)/C(=C\C3=CN=CC=C3)/NC(=O)C4=CC=CC=C4Br |
Product Overview
2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide (CAS 799770-60-8), with molecular formula C25H21BrN4O2 and molecular weight 488.08 g/mol. IUPAC: 2-bromo-N-[(E)-3-[2-(1H-indol-3-yl)ethylamino]-3-oxo-1-pyridin-3-ylprop-1-en-2-yl]benzamide.
Chemical Property Profile of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide
Property Insights of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide
The XLogP value of 4.4552 indicates that 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 86.88 Ų falls within the moderate polarity range, balancing permeability and solubility for 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide. Following Lipinski's Rule of Five, 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide has 3 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide?
The CAS number of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide is 799770-60-8.
What is the molecular formula of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide?
The molecular formula of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide is C25H21BrN4O2.
What is the molecular weight of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide?
The molecular weight of 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide is 488.08 g/mol.
Where can I buy 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide?
You can request a quote for 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide?
Yes, KEHONG BIO provides custom synthesis services for 2-Bromo-N-{(E)-1-[2-(1H-indol-3-yl)-ethylcarbamoyl]-2-pyridin-3-yl-vinyl}-benzamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.